Patterns of viral load decline with telaprevir-based therapy in patients with genotype 1 chronic HCV infection

HCV RNA profiles with telaprevir/Peg-IFN/RBV are different from those with Peg-IFN/RBV alone. It is important that clinicians understand these HCV RNA profiles and monitor patient viral load in order to apply futility rules correctly.